Boothbay Fund Management, LLC Harpoon Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $19,936 - $56,223	-11,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $18,187 - $32,312	-2,308 Reduced 17.09%	11,200 $88,000
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $254,504 - $428,474	-18,429 Reduced 57.7%	13,508 $187,000
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $563,688 - $771,597	31,937 New	31,937 $668,000
Q1 2020 May 15, 2020	SELL	$10.74 - $16.32 $365,160 - $554,880	-34,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $439,960 - $699,720	34,000 New	34,000 $503,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.